Physician

Ghazi Antoun Ghanem, MD

According to 2025 Medicare claims, Ghazi Ghanem, MD (NPI: 1669540423) practices infectious disease in the Casper, WY market, with the plurality of this provider's patient population coming from Natrona, WY. This provider's primary affiliated billing organization is ROCKY MOUNTAIN INFECTIOUS DISEASES (NPI: 1497833180; TIN: 830326365) and primary practice location at 82601-2239. Ghanem is affiliated with the CoreHealth Alliance LLC (ACO ID: A5645), participating under the MSSP model.

Ghanem's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 501 traditional Medicare patients, billed 141,832 HCPCS/CPT codes, and received $262,528 in Medicare payments. The top billing code was 99214 (Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more). Part D data shows 188 prescription claims across 83 beneficiaries totaling $159,922 in drug costs, led by Biktarvy (Bictegrav/Emtricit/Tenofov Ala). 2023 DME data shows 16 claims. Open Payments data shows 1 records totaling $37. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has moved from a higher plateau to a lower plateau, from $504,430 to $262,528. Similarly, Part D prescription costs started with an early spike, then settled into a lower baseline, moving from $902,142 to $159,922. In contrast, DME billing represents a smaller volume and started with an early spike, then settled into a lower baseline, moving from $14,185 to $2,358.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Part B Carrier Billing Trend. X-axis: year 2015-2024. Y-axis: Medicare payment, unit: USD. Field: Tot_Mdcr_Pymt_Amt. Source: Medicare Physician & Other Practitioners by Provider.0$492K$985K2015 Medicare payment: $504,430 (USD; Tot_Mdcr_Pymt_Amt)2016 Medicare payment: $516,664 (USD; Tot_Mdcr_Pymt_Amt)2017 Medicare payment: $754,716 (USD; Tot_Mdcr_Pymt_Amt)2018 Medicare payment: $984,957 (USD; Tot_Mdcr_Pymt_Amt)2019 Medicare payment: $565,214 (USD; Tot_Mdcr_Pymt_Amt)2020 Medicare payment: $197,072 (USD; Tot_Mdcr_Pymt_Amt)2021 Medicare payment: $230,754 (USD; Tot_Mdcr_Pymt_Amt)2022 Medicare payment: $395,149 (USD; Tot_Mdcr_Pymt_Amt)2023 Medicare payment: $340,729 (USD; Tot_Mdcr_Pymt_Amt)2024 Medicare payment: $262,528 (USD; Tot_Mdcr_Pymt_Amt)2015201620172018201920202021202220232024
YearPatientsClm LinesPayment
2015663283,209$504,430
2016659235,284$516,664
2017654228,809$754,716
2018733446,101$984,957
2019747241,488$565,214
202048182,515$197,072
2021526117,184$230,754
2022649253,331$395,149
2023583206,761$340,729
2024501141,832$262,528

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Part D Events Trend. X-axis: year 2015-2024. Y-axis: Drug cost, unit: USD. Field: Tot_Drug_Cst. Source: Medicare Part D Prescribers by Provider.0$451K$902K2015 Drug cost: $902,142 (USD; Tot_Drug_Cst)2016 Drug cost: $618,187 (USD; Tot_Drug_Cst)2017 Drug cost: $229,754 (USD; Tot_Drug_Cst)2018 Drug cost: $162,035 (USD; Tot_Drug_Cst)2019 Drug cost: $169,699 (USD; Tot_Drug_Cst)2020 Drug cost: $49,029 (USD; Tot_Drug_Cst)2021 Drug cost: $41,933 (USD; Tot_Drug_Cst)2022 Drug cost: $18,905 (USD; Tot_Drug_Cst)2023 Drug cost: $189,136 (USD; Tot_Drug_Cst)2024 Drug cost: $159,922 (USD; Tot_Drug_Cst)2015201620172018201920202021202220232024
YearPatientsClaimsDrug Cost
2015127425$902,142
2016126476$618,187
2017105363$229,754
2018105324$162,035
201997204$169,699
202050102$49,029
202152120$41,933
202282132$18,905
202382244$189,136
202483188$159,922

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

DME Billing Trend. X-axis: year 2015-2024. Y-axis: Medicare payment, unit: USD. Field: DME_Suplr_Mdcr_Pymt_Amt. Source: Medicare DME, Devices & Supplies by Referring Provider.0$5.9K$12K2015 Medicare payment: $6,197 (USD; DME_Suplr_Mdcr_Pymt_Amt)2016 Medicare payment: $11,182 (USD; DME_Suplr_Mdcr_Pymt_Amt)2017 Medicare payment: $11,847 (USD; DME_Suplr_Mdcr_Pymt_Amt)2018 Medicare payment: $9,765 (USD; DME_Suplr_Mdcr_Pymt_Amt)2019 Medicare payment: $2,735 (USD; DME_Suplr_Mdcr_Pymt_Amt)2020 Medicare payment: $713 (USD; DME_Suplr_Mdcr_Pymt_Amt)2021 Medicare payment: $1,296 (USD; DME_Suplr_Mdcr_Pymt_Amt)2022 Medicare payment: $1,734 (USD; DME_Suplr_Mdcr_Pymt_Amt)2023 Medicare payment: $1,306 (USD; DME_Suplr_Mdcr_Pymt_Amt)2015201620172018201920202021202220232024
YearPatientsClaimsPayment
2015359901$6,197
20163991,366$11,182
20174581,216$11,847
2018179691$9,765
201925145$2,735
2020N/R16$713
2021N/R27$1,296
20221244$1,734
2023N/R16$1,306
2024N/RN/RN/R

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

CodeDescriptionPatientsClm LinesTotal Payment
99214Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more243444$96
99232Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes92149$60
96365Infusion into a vein for therapy, prevention, or diagnosis, 1 hour or less121533$48
36415Insertion of needle into vein for collection of blood sample120198$8
85025Complete blood cell count (red cells, white blood cell, platelets), automated test and automated differential white blood cell count82138$7

Top 5 Part D drugs in 2024

By total drug costs.

DrugGenericClaimsTotal Day SupplyTotal Drug Cost
BiktarvyBictegrav/Emtricit/Tenofov Ala16480$64,448
Doxycycline HyclateDoxycycline Hyclate21828$798
CefuroximeCefuroxime Axetil11233$773
CephalexinCephalexin25636$511
AmoxicillinAmoxicillin11257$87

Top 5 DME services in 2024

No connected or detailed DME service-level records for 2024.

Open Payments Summary in 2024

CategoryDefinitionRecordsTotal Reported AmountTop Related Entity
General PaymentsReported payment or transfer-of-value amount.1$37Boston Scientific Corporation
Research PaymentsReported research-related payment or transfer-of-value amount.0$0N/R
Ownership / Investment InterestsReported value of ownership or investment interests.0$0N/R

FAQ

What Medicare data is available for Ghazi Antoun Ghanem, MD?

Tedicare shows public-source Medicare data for Ghazi Antoun Ghanem, MD (NPI 1669540423), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Ghazi Antoun Ghanem, MD have ACO affiliation data?

Ghazi Antoun Ghanem, MD is shown with ACO affiliation data for CoreHealth Alliance LLC (MSSP, ACO ID A5645).

What billing organization is linked to Ghazi Antoun Ghanem, MD?

Ghazi Antoun Ghanem, MD is linked to ROCKY MOUNTAIN INFECTIOUS DISEASES (billing NPI 1497833180) in the available physician profile data.

Does Ghazi Antoun Ghanem, MD have Open Payments data?

Ghazi Antoun Ghanem, MD has 1 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.